---
title: SEQENS vs Sky Pharma
slug_a: seqens
slug_b: skypharma-co
site: cdmo
review_signal_gate: closed
canonical_path: /compare/seqens/skypharma-co
generated_by: BioBM Editorial AI
---

# SEQENS vs Sky Pharma

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

SEQENS (seqens) is listed for cdmo. Global CDMO and specialty ingredients manufacturer with 16 production sites and 9 R&D centres offering custom development and GMP manufacturing of pharmaceutical APIs, intermediates, and specialty chemicals from preclinical to commercial scale.

Services: 8. Modalities: 1. Indications: 0. Locations: 15. Certifications: 9. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (15).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Sky Pharma (skypharma-co) is listed for cdmo. Sky Pharma is a pharmaceutical supply partner offering custom manufacturing, API sourcing, excipient procurement, and finished dosage form distribution with integrated quality, regulatory, and cold-chain logistics support.

Services: 5. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.